These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2945956)

  • 1. Experimental striatal degeneration induced by kainic acid administration: relevance to morphological changes in Huntington's disease.
    Marasigan SM; Sato M; Miyoshi K
    Jpn J Psychiatry Neurol; 1986 Mar; 40(1):113-21. PubMed ID: 2945956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic evidence of a primary response of gila to kainic acid administration into the rat neostriatum; studied in vivo and in vitro.
    Matyja E
    Exp Neurol; 1986 Jun; 92(3):609-23. PubMed ID: 2940109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterograde and transsynaptic degeneration 'en cascade' in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington's disease.
    Krammer EB
    Brain Res; 1980 Aug; 196(1):209-21. PubMed ID: 6446952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural evaluation of the damage of postsynaptic elements after kainic acid injection into the rat neostriatum.
    Matyja E
    J Neurosci Res; 1986; 15(3):405-13. PubMed ID: 3701889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage.
    Coyle JT; Molliver ME; Kuhar MJ
    J Comp Neurol; 1978 Jul; 180(2):301-23. PubMed ID: 659663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and distant neuronal degeneration following intrastriatal injection of kainic acid.
    Zaczek R; Simonton S; Coyle JT
    J Neuropathol Exp Neurol; 1980 May; 39(3):245-64. PubMed ID: 6154134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal organization of fetal striatal grafts in kainate- and sham-lesioned rat caudate nucleus: light- and electron-microscopic observations.
    DiFiglia M; Schiff L; Deckel AW
    J Neurosci; 1988 Apr; 8(4):1112-30. PubMed ID: 3357012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kainic acid induced seizures: neurochemical and histopathological changes.
    Sperk G; Lassmann H; Baran H; Kish SJ; Seitelberger F; Hornykiewicz O
    Neuroscience; 1983 Dec; 10(4):1301-15. PubMed ID: 6141539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An animal model for Huntington's disease.
    Coyle JT
    Biol Psychiatry; 1979 Apr; 14(2):251-76. PubMed ID: 38864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
    Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological changes of striatal dopaminergic presynaptic boutons following intrastriatal kainate injection.
    Moriizumi T; Takada M; Hattori T
    Neuropharmacology; 1991 Jul; 30(7):813-7. PubMed ID: 1922691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study.
    Schwarcz R; Hökfelt T; Fuxe K; Jonsson G; Goldstein M; Terenius L
    Exp Brain Res; 1979 Oct; 37(2):199-216. PubMed ID: 40808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An animal model of Huntington's disease: the development of histopathological changes within the neurotoxic lesions of the striatum in long-term surviving rats].
    Mazurová Y; Osterreicher J; Valousková V
    Acta Medica (Hradec Kralove) Suppl; 2002; 45(2):53-64. PubMed ID: 19569580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease.
    Morton AJ; Nicholson LF; Faull RL
    Neuroscience; 1993 Mar; 53(1):159-68. PubMed ID: 7682296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.
    Higatsberger MR; Sperk G; Bernheimer H; Shannak KS; Hornykiewicz O
    Exp Brain Res; 1981; 44(1):93-6. PubMed ID: 6456150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract.
    McGeer EG; McGeer PL; Singh K
    Brain Res; 1978 Jan; 139(2):381-3. PubMed ID: 146535
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry.
    Ferrante RJ; Kowall NW; Richardson EP
    J Neurosci; 1991 Dec; 11(12):3877-87. PubMed ID: 1836019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural alterations in rat striatum in vitro induced by sera from patients with Huntington's disease.
    Renkawek K; Kida E
    Neuropatol Pol; 1986; 24(3):387-98. PubMed ID: 2951615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.